[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Apoptosis Assay Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Assay Type (Caspase, DNA Fragmentation), By Technique, By End Use, By Region, And Segment Forecasts, 2020 - 2027

September 2020 | 140 pages | ID: A91421A29552EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 72 Business Hours

Apoptosis Assay Market Growth & Trends
The global apoptosis assay market size is expected to reach USD 7.5 billion by 2027, expanding at a CAGR of 7.6%, according to a new report by Grand View Research, Inc. Extensive research activities on expanding applications of drug-induced apoptosis assays have propelled the inclination of pharmaceutical manufacturers towards incorporating cell cycle products in the drug discovery and designing process.

The introduction of affordable and easy to perform kits that can be accommodated in complex experiments is expected to minimize the overhead costs of apoptosis experiments. Companies are providing highly precise reagents and lot-to-lot reproducibility in sample measurements.

Professionals at pharmaceutical companies are making use of cell-cycle inhibitors and Apoptosis-Inducing Factors (AIF)/ molecules to explore possible drug targets. Also, high demand for caspase activity assays along with Bcl-2 protein family across pharmaceutical companies for apoptosis detection has been observed in recent years. Biotechnology companies are enhancing quantification techniques to enable real-time monitoring of apoptotic cellular dynamics.

The presence of established guidelines and protocols for cell-potency assays has strengthened the development of efficient cell-death detection assays. Whereas, stringent regulations with respect to the approval of cell-potency assays are ensuring successful uptake of market products launched.

The flow cytometry segment dominated the market and accounted for the largest revenue share in 2019. This is attributed to the increasing adoption of the technique among researchers. It helps in finding the difference between intact mitochondria (healthy cells) and permeabilized mitochondria (cells undergoing death). The segment is anticipated to grow fast over the forecast period.

The pharmaceutical and biotechnology segment dominated the market in 2019 and is anticipated to continue its dominance over the forecast period. This is attributed to the rising incidence of cancer and neurodegenerative disorders. In addition, the growing significance of programmed cell death or apoptosis to treat chronic diseases is driving the segment growth.

Apoptosis Assay Market Report Highlights
  • The kits segment dominated the market and accounted for a revenue share of around 50.0% owing to increasing investment by key market players
  • Increase in the demand for fluorochrome-labeled inhibitors of caspases has made reagents the fastest growing product segment in the market
  • Application of these inhibitors with other techniques is anticipated to enhance the apoptosis assessment, thereby driving segment growth
  • Owing to the wide adoption and easy availability of products, flow cytometry is estimated to account for a substantial share of approximately 35.0% in 2019
  • The increasing significance of continuous monitoring of programmed cell death across novel drug discoveries and development of advanced therapeutics is set to propel market growth
  • North America has dominated the market in terms of revenue share in 2019, and Asia Pacific is expected to witness the fastest growth in the coming years as a result of the expanding CRO landscape in the region
  • Key companies are competing in terms of a combination of products and services in order to maintain market share.
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Research Methodology
1.2 Research Assumptions
  1.2.1 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
  1.4.1 Purchased Database
  1.4.2 GVR’s Internal Database
  1.4.3 Secondary Sources
  1.4.4 Primary Research
  1.4.5 Details of Primary Research
1.5 Information or Data Analysis
  1.5.1 Data analysis of cell-based assays market
  1.5.2 Cell-based assay types addressed by market players
  1.5.3 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
  1.7.1 Commodity Flow Analysis
    1.7.1.1 Approach 1: Commodity Flow Approach
    1.7.1.2 Approach 2: Country-wise market estimation using the bottom-up approach
1.8 Global Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
  1.11.1 Objective 1:
  1.11.2 Objective 2:

CHAPTER 2 MARKET DEFINITIONS

CHAPTER 3 EXECUTIVE SUMMARY

3.1 Market Summary

CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE

4.1 Market Segmentation
4.2 Apoptosis Assay Market Lineage Outlook
  4.2.1 Parent market outlook
    4.2.1.1 Top Innovators Of Cell-Based Assay Industry: Products & Services
4.3 Penetration and Growth Prospect Mapping

CHAPTER 5 INDUSTRY OUTLOOK

5.1 Market Driver Analysis
  5.1.1 Role of apoptosis assays in drug discovery
  5.1.2 Rising demand for apoptosis pathways among pharmaceutical companies
    5.1.2.1 Pharmaceutical Companies And Apoptosis Assay Industry
  5.1.3 Advances in detection of apoptosis
5.2 Market Restraint Analysis
  5.2.1 Lack of unequivocal information on cell death occurrence

CHAPTER 6 BUSINESS ENVIRONMENT ANALYSIS

6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
  6.1.1 Political landscape
    6.1.1.1 Strengths
    6.1.1.2 Weaknesses
    6.1.1.3 Opportunities
    6.1.1.4 Threats
  6.1.2 Economic landscape
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
  6.1.3 Social landscape
    6.1.3.1 Strengths
    6.1.3.2 Weaknesses
    6.1.3.3 Opportunities
    6.1.3.4 Threats
  6.1.4 Technology landscape
    6.1.4.1 Strengths
    6.1.4.2 Weaknesses
    6.1.4.3 Opportunities
    6.1.4.4 Threats
6.2 Porter’s Five Forces Analysis
6.3 Market entry strategies

CHAPTER 7 COMPETITIVE ANALYSIS

7.1 Market Impact Analysis by Key Participants
  7.1.1 Ansoff matrix
  7.1.2 Company/Competition Categorization (Primary & Secondary market participants)
  7.1.3 Innovators
7.2 Vendor Landscape
  7.2.1 List of key suppliers and channel partners
7.3 Public Companies
  7.3.1 Market Participant Position Analysis

CHAPTER 8 PRODUCTS BUSINESS ANALYSIS

8.1 Apoptosis Assay Market: Products Movement Analysis
8.2 Kits
  8.2.1 Apoptosis assay kits market estimates and forecasts, 2016 - 2027 (USD Million)
8.3 Reagents
  8.3.1 Apoptosis assay reagents market estimates and forecast, 2016 - 2027 (USD Million)
8.4 Instruments
  8.4.1 Apoptosis assay instruments market estimates and forecast, 2016 - 2027 (USD Million)

CHAPTER 9 TECHNIQUE BUSINESS ANALYSIS

9.1 Apoptosis Assay Market: Technique Movement Analysis
9.2 Flow Cytometry
  9.2.1 Flow cytometry-based apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
9.3 Fluorescence Microscopy
  9.3.1 Fluorescence microscopy-based apoptosis assay market estimates and forecast, 2016 - 2027
9.4 Spectrophotometry
  9.4.1 Spectrophotometry-based apoptosis assay market estimates and forecast, 2016 - 2027
9.5 Other Techniques
  9.5.1 Other techniques-based apoptosis assay market estimates and forecast, 2016 - 2027

CHAPTER 10 ASSAY TYPE BUSINESS ANALYSIS

10.1 Apoptosis Assay Market: Assay Type Movement Analysis
10.2 Caspase Assays
  10.2.1 Caspase-based apoptosis assay market estimates and forecast, 2016 - 2027
10.3 DNA Fragmentation Assays
  10.3.1 DNA fragmentation-based apoptosis assay market estimates and forecast, 2016 - 2027
10.4 Cell Permeability Assays
  10.4.1 Cell permeability-based apoptosis assay market estimates and forecast, 2016 - 2027
10.5 Mitochondrial Assays
  10.5.1 Mitochondrial-based apoptosis Assay market estimates and forecast, 2016 - 2027

CHAPTER 11 END-USE BUSINESS ANALYSIS

11.1 Apoptosis Assay Market: End-use Movement Analysis
11.2 Pharmaceutical & Biotechnology Companies
  11.2.1 Apoptosis assay market for Pharmaceutical & Biotechnology Companies estimates and forecast, 2016 - 2027 (USD million)
11.3 Hospital & Diagnostic Laboratories
  11.3.1 Apoptosis assay market for hospital & diagnostic laboratories estimates and forecast, 2016 - 2027 (USD million)
11.4 Academic & Research Institutes
  11.4.1 Apoptosis assay market for Academic & research institutes estimates and forecast, 2016 - 2027 (USD million)

CHAPTER 12 REGIONAL BUSINESS ANALYSIS

12.1 Apoptosis Assay Market: Regional Movement Analysis
12.2 North America
  12.2.1 North America apoptosis assay market, SWOT Analysis
  12.2.2 North America apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.2.3 The U.S.
    12.2.3.1 The U.S. apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
12.3 Canada
    12.3.1.1 Canada apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
12.4 Europe
  12.4.1 Europe apoptosis assay market, SWOT Analysis
  12.4.2 Europe apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.4.3 Germany
    12.4.3.1 Germany apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.4.4 The U.K.
    12.4.4.1 The U.K. apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.4.5 France
    12.4.5.1 France apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.4.6 Spain
    12.4.6.1 Spain apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.4.7 Italy
    12.4.7.1 Italy apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
12.5 Asia-Pacific
  12.5.1 Asia Pacific, SWOT Analysis
  12.5.2 Asia Pacific apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.5.3 Japan
    12.5.3.1 Japan apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.5.4 China
    12.5.4.1 China apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.5.5 India
    12.5.5.1 India apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
12.6 Latin America
  12.6.1 Latin America apoptosis assay market, SWOT Analysis
  12.6.2 Latin America apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.6.3 Brazil
    12.6.3.1 Brazil apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.6.4 Mexico
    12.6.4.1 Mexico apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
12.7 Middle East and Africa
  12.7.1 Middle East & Africa (MEA) apoptosis assay market, SWOT Analysis
  12.7.2 MEA apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.7.3 South Africa
    12.7.3.1 South Africa apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
  12.7.4 Saudi Arabia
    12.7.4.1 Saudi Arabia apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)

CHAPTER 13 COMPANY PROFILES

13.1 Company Profiles
  13.1.1 Bio-Techne
    13.1.1.1 Company overview
    13.1.1.2 Financial Performance
    13.1.1.3 Product benchmarking
  13.1.2 Biotium
    13.1.2.1 Company overview
    13.1.2.2 Product benchmarking
  13.1.3 GeneCopoeia, Inc.
    13.1.3.1 Company overview
    13.1.3.2 Product benchmarking
  13.1.4 Becton, Dickinson & Company (BD)
    13.1.4.1 Company overview
    13.1.4.2 Financial performance
    13.1.4.3 Product benchmarking
  13.1.5 Thermo Fisher Scientific, Inc.
    13.1.5.1 Company overview
    13.1.5.2 Financial performance
    13.1.5.3 Product benchmarking
  13.1.6 Promega Corporation
    13.1.6.1 Company overview
    13.1.6.2 Product benchmarking
  13.1.7 Sartorius AG
    13.1.7.1 Company overview
    13.1.7.2 Financial performance
    13.1.7.3 Product benchmarking
  13.1.8 Merck KGaA
    13.1.8.1 Company overview
    13.1.8.2 Sigma-Aldrich, Inc.
      13.1.8.2.1 Company overview
    13.1.8.3 Merck Millipore
      13.1.8.3.1 Company overview
    13.1.8.4 Financial performance
    13.1.8.5 Product benchmarking
  13.1.9 Abcam plc.
    13.1.9.1 Company overview
    13.1.9.2 Financial performance
    13.1.9.3 Product benchmarking
  13.1.10 Takara Bio Inc.
    13.1.10.1 Company overview
    13.1.10.2 Financial performance
    13.1.10.3 Product benchmarking
  13.1.11 Bio-Rad Laboratories
    13.1.11.1 Company overview
    13.1.11.2 Financial performance
    13.1.11.3 Product benchmarking
  13.1.12 Creative Bioarray
    13.1.12.1 Company overview
    13.1.12.2 Financial performance
    13.1.12.3 Product benchmarking
LIST OF TABLES

Table 1 List of secondary sources
Table 2 Top innovators of cell-based assay industry
Table 3 Commercially developed apoptosis assay kits by local players in the market
Table 4 Commercial apoptosis assay reagent offerings (excluded from the kit), Novus Biologicals
Table 5 Apoptosis assay kits manufactured by Life Technologies Corporation that are compatible with Attune acoustic focusing cytometer
Table 6 Snapshot of commercially developed apoptosis assays and probes designed for fluorescence imaging/ microscopy
Table 7 Commercially available caspase-based apoptosis assay products: Promega Corporation
Table 8 Commercially manufactured DNA fragmentation-based apoptosis assay products: Emerging & well-established companies
Table 9 Commercially manufactured DNA fragmentation-based apoptosis assay products: Emerging & well-established companies
Table 10 Market participants in this segment and associated product offerings
Table 11 North America apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 12 North America apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 13 North America apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 14 North America apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 15 The U.S. apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 16 The U.S. apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 17 The U.S. apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 18 The U.S. apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 19 Canada apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 20 Canada apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 21 Canada apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 22 Canada apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 23 Europe apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 24 Europe apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 25 Europe apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 26 Europe apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 27 Germany apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 28 Germany apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 29 Germany apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 30 Germany apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 31 The U.K. apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 32 The U.K. apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 33 The U.K. apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 34 The U.K. apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 35 France apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 36 France apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 37 France apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 38 France apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 39 Spain apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 40 Spain apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 41 Spain apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 42 Spain apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 43 Italy apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 44 Italy apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 45 Italy apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 46 Italy apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 47 Asia Pacific apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 48 Asia Pacific apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 49 Asia Pacific apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 50 Asia Pacific apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 51 Japan apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 52 Japan apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 53 Japan apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 54 Japan apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 55 China apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 56 China apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 57 China apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 58 China apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 59 India apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 60 India apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 61 India apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 62 India apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 63 Latin America apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 64 Latin America apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 65 Latin America apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 66 Latin America apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 67 Brazil apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 68 Brazil apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 69 Brazil apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 70 Brazil apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 71 Mexico apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 72 Mexico apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 73 Mexico apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 74 Mexico apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 75 MEA apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 76 MEA apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 77 MEA apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 78 MEA apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 79 South Africa apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 80 South Africa apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 81 South Africa apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 82 South Africa apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
Table 83 Saudi Arabia apoptosis assay market estimates and forecasts, by product, 2016 - 2027 (USD Million)
Table 84 Saudi Arabia apoptosis assay market estimates and forecasts, by technique, 2016 - 2027 (USD Million)
Table 85 Saudi Arabia apoptosis assay market estimates and forecasts, by assay type, 2016 - 2027 (USD Million)
Table 86 Saudi Arabia apoptosis assay market estimates and forecasts, by end-use, 2016 - 2027 (USD Million)
LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 End-use landscape: Apoptosis assay product penetration
Fig. 5 Data analysis of cell-based assays market
Fig. 6 Cell-based assay types addressed by market players
Fig. 7 Market research approaches
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Apoptosis Assay market snapshot
Fig. 12 Apoptosis Assay Market Segmentation
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Apoptosis Assay market driver impact
Fig. 15 Apoptosis Assay market restraint impact
Fig. 16 Porter’s Five Forces Analysis
Fig. 17 Factors impacting market entry strategies
Fig. 18 Ansoff Matrix
Fig. 19 Competition Categorization
Fig. 20 Market Participant Revenue Analysis (USD Million): 2019
Fig. 21 Market Participant Gross Profit Analysis (USD Million): 2019
Fig. 22 Apoptosis assay market: Products outlook and key takeaways
Fig. 23 Apoptosis assay market: Products Movement Analysis
Fig. 24 Apoptosis assay kits market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 25 Apoptosis assay reagents market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 26 Apoptosis assay instruments market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 27 Apoptosis assay market: Technique outlook and key takeaways
Fig. 28 Apoptosis assay market: Technique movement analysis
Fig. 29 Flow cytometry-based apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 30 Fluorescence microscopy-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 31 Spectrophotometry-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 32 Other Techniques-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 33 Apoptosis Assay market: Assay type outlook and key takeaways
Fig. 34 Apoptosis Assay market: Assay type movement analysis
Fig. 35 Caspase-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 36 DNA fragmentation-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 37 Cell permeability-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 38 Mitochondrial-based apoptosis assay market estimates and forecast, 2016 - 2027
Fig. 39 Apoptosis assay market: End-use outlook and key takeaways
Fig. 40 Apoptosis assay market: End-use movement analysis
Fig. 41 Apoptosis market for pharmaceutical & biotechnology companies estimates and forecast, 2016 - 2027 (USD million)
Fig. 42 Apoptosis market for hospital & diagnostic laboratories estimates and forecast, 2016 - 2027 (USD Million)
Fig. 43 Apoptosis Market for academic & research institutes estimates and forecast, 2016 - 2027 (USD Million)
Fig. 44 Apoptosis assay market: Regional outlook and key takeaways
Fig. 45 Apoptosis assay market: Regional movement analysis
Fig. 46 North America apoptosis assay market overview
Fig. 47 North America apoptosis assay market, SWOT analysis
Fig. 48 North America apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 49 The U.S.
Fig. 50 The U.S. apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 51 Canada apoptosis assay market overview
Fig. 52 Canada apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 53 Europe apoptosis assay market overview
Fig. 54 Europe apoptosis assay market, SWOT analysis
Fig. 55 Europe apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 56 Germany apoptosis assay market overview
Fig. 57 Germany apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 58 The U.K. apoptosis assay market overview
Fig. 59 The U.K. apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 60 France apoptosis assay market overview
Fig. 61 France apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 62 Spain apoptosis assay market overview
Fig. 63 Spain apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 64 Italy apoptosis assay market overview
Fig. 65 Italy apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 66 Asia Pacific apoptosis assay market overview
Fig. 67 Asia Pacific, SWOT
Fig. 68 Asia Pacific apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 69 Japan apoptosis assay market overview
Fig. 70 Japan apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 71 China apoptosis assay market overview
Fig. 72 China apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 73 India apoptosis assay market overview
Fig. 74 India apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 75 Latin America apoptosis assay market overview
Fig. 76 Latin America apoptosis assay market, SWOT analysis
Fig. 77 Latin America apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 78 Brazil apoptosis assay market overview
Fig. 79 Brazil apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 80 Mexico apoptosis assay market overview
Fig. 81 Mexico apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 82 Middle East & Africa apoptosis assay market overview
Fig. 83 Middle East & Africa apoptosis assay market, SWOT analysis
Fig. 84 MEA apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 85 South Africa apoptosis assay market overview
Fig. 86 South Africa apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 87 Saudi Arabia apoptosis assay market overview
Fig. 88 Saudi Arabia apoptosis assay market estimates and forecast, 2016 - 2027 (USD Million)


More Publications